학술논문

Daratumumab-Mediated lysis of primary multiple myeloma cells is enhanced in combination with the human Anti-KIR antibody IPH2102 and lenalidomide
Document Type
Article
Source
In: Haematologica. (Haematologica, 2015, 100(2):263-268)
Subject
Language
English
ISSN
15928721
03906078